News

Medigene strengthens its patent portfolio with a US patent on a tagged TCR

SHOW RELEASE

Medigene announces participation at six upcoming investor and scientific conferences

SHOW RELEASE

Expitope 2.0 helps to identify safer antigens for immunotherapy of cancer

SHOW RELEASE

Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells

SHOW RELEASE

Medigene sells US-rights for VeregenĀ® and raises financial guidance 2017

SHOW RELEASE

Medigene announces participation at upcoming investor and scientific conferences

SHOW RELEASE

Patient recruitment completed for Phase I/II DC vaccine trial in AML

SHOW RELEASE

Medigene AG reports nine months' results 2017

SHOW RELEASE

Medigene participates at six conferences in November

SHOW RELEASE

Medigene and academic partners publish a method to identify T cell receptors against viral antigens

SHOW RELEASE